Percutaneous Edge-to-Edge Repair of Atrioventricular Valves in Congenital Heart Disease
TEER for carefully selected patients with CHD and severe AVVR was safe and effective with notable improvements in regurgitation and clinical symptoms. Our findings highlight important considerations for planning and implementation of TEER in this patient population.
Authors
- Iván Gómez Blázquez
- Rafael Hirsch
- Amos Levi (ORCID: https://orcid.org/0009-0004-6148-7235)
- Francesco Maisano (ORCID: https://orcid.org/0000-0002-3691-1709)
- Antonio Popolo Rubbio (ORCID: https://orcid.org/0000-0002-2451-4626)
- Gerard Martí
- Fernando Sarnago
- Shimon Kolker
- Yassin Belahnech (ORCID: https://orcid.org/0000-0003-0723-1023)
- Ran Kornowski
- Nicola Buzzatti (ORCID: https://orcid.org/0000-0002-7713-3739)
- Francesco Bedogni (ORCID: https://orcid.org/0000-0002-4975-6605)
- Leor Perl (ORCID: https://orcid.org/0000-0002-0625-7937)
- Raffaele Esposito (ORCID: https://orcid.org/0000-0002-6706-1129)
- Yaron Shapira
Institutions
- Valve (United States) (US)
- Vita-Salute San Raffaele University (IT)
- Rabin Medical Center (IL)
- IRCCS Policlinico San Donato (IT)
- Hospital Universitario 12 De Octubre (ES)
- Vall d'Hebron Hospital Universitari (ES)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- JACC Advances
- Published
- 2025-12-04
- DOI
- https://doi.org/10.1016/j.jacadv.2025.102408
- Primary Topic
- Congenital Heart Disease Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00